Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Kakkis Emil D
Relationship:  
City:   Novato
State:   CA
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   603,534    

Indirect Shares

   2,268,639      
Direct Value   $26,147,077    

Indirect Value

   $91,288,842      
Total Shares   2,872,173      
Total Value   $117,435,919      


Biomarin Pharmaceutical Inc $3,511,609 Ultragenyx Pharmaceutical Inc $22,635,468 Biomarin Pharmaceutical Inc $3,511,609 Ultragenyx Pharmaceutical Inc $22,635,468
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Chief Medical Officer 2009-03-02 39,621 2009-03-02 4,654    Premium*  
            Ultragenyx Pharmaceutical Inc RARE 2024-03-01 563,913 2024-03-01 2,263,985    Premium*  
* Premium Members only  

Records found :    106         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Medical Officer   •       –      –    2008-04-01 4 AS $35.65 $291,120 D/D (8,143) 96,021 0 -
BMRN Biomarin Pharmaceutical I... Chief Medical Officer   •       –      –    2008-05-01 4 AS $37.31 $674,857 D/D (18,000) 162,804 0 -
BMRN Biomarin Pharmaceutical I... Chief Medical Officer   •       –      –    2008-06-02 4 AS $37.57 $677,367 D/D (18,000) 160,804 0 -
BMRN Biomarin Pharmaceutical I... Chief Medical Officer   •       –      –    2008-07-07 4 AS $27.90 $505,076 D/D (18,000) 145,304 0 -
BMRN Biomarin Pharmaceutical I... Chief Medical Officer   •       –      –    2008-08-01 4 AS $32.34 $584,578 D/D (18,000) 127,304 0 -
BMRN Biomarin Pharmaceutical I... Chief Medical Officer   •       –      –    2008-09-02 4 AS $30.19 $543,384 D/D (18,000) 115,304 0 -
BMRN Biomarin Pharmaceutical I... Chief Medical Officer   •       –      –    2008-10-01 4 AS $26.27 $472,878 D/D (18,000) 115,304 0 -
BMRN Biomarin Pharmaceutical I... CHIEF MEDICAL OFFICER   •       –      –    2008-12-01 4 AS $15.87 $269,790 D/D (17,000) 39,621 0 -
BMRN Biomarin Pharmaceutical I... Chief Medical officer   •       –      –    2009-01-02 4 AS $17.57 $298,690 D/D (17,000) 39,621 0 -
BMRN Biomarin Pharmaceutical I... Chief Medical Officer   •       –      –    2009-02-03 4 AS $19.14 $325,373 D/D (17,000) 39,621 0 -
BMRN Biomarin Pharmaceutical I... Chief Medical Officer   •       –      –    2009-03-02 4 AS $11.70 $92,396 D/D (7,897) 39,621 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2015-10-30 4 AS $98.63 $1,991,407 D/D (20,000) 615,640 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2015-11-30 4 AS $96.46 $1,965,427 D/D (20,000) 595,640 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2015-12-30 4 AS $113.30 $1,666,198 D/D (14,502) 581,138 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2015-12-31 4 AS $112.91 $624,294 D/D (5,498) 575,640 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2016-04-15 4 AS $69.46 $1,406,554 D/D (20,000) 537,519 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2016-05-16 4 AS $59.37 $1,199,095 D/D (20,000) 517,519 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2016-07-15 4 AS $50.61 $1,016,909 D/D (20,000) 507,147 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2016-08-15 4 AS $67.39 $1,352,251 D/D (20,000) 487,147 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2016-10-14 4 AS $61.97 $1,260,360 D/D (20,000) 467,147 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2016-11-15 4 AS $79.39 $1,625,753 D/D (20,000) 447,147 0 -
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2020-07-13 4 AS $85.35 $3,414,000 I/I (40,000) 2,419,741 0 %
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2020-09-01 4 AS $82.63 $2,478,900 I/I (30,000) 2,389,741 0 %
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2020-11-02 4 AS $96.82 $2,904,600 I/I (30,000) 2,359,741 0 %
RARE Ultragenyx Pharmaceutical... President & CEO   •       •      –    2021-01-04 4 AS $136.90 $4,107,000 I/I (30,000) 2,329,741 0 %
  106  Records found
  1   2  3   4   5      
  Page 2 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us